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Summary
Prokaryotes are generally characterized by vast genomic diversity that has been shaped
by mutations, horizontal gene transfer, bacteriocins and phage predation. Enormous gene-
tic diversity has developed as a result of stresses imposed in harsh environments and the
ability of microorganisms to adapt. Two examples of prokaryotic diversity are presented:
on intraspecies level, exemplified by Escherichia coli, and the diversity of the hypersaline
environment, with the discussion of food-related health issues and biotechnological poten-
tial.
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Introduction
Prokaryotes may exhibit vast intraspecies as well as
intra-habitat genomic diversity. The basis of diversity
among bacteria are mutations in concert with short gene-
ration times, horizontal gene transfer, production of bac-
teriocins and phage predation. Man-induced influences,
namely indiscriminative antibiotic use, various food ad-
ditives, intensive animal husbandry and global travel have
in the last decades promoted rapid evolution and dis-
semination of antibiotic resistance and virulence factors.
In addition, prokaryotes inhabit extremely diverse
ecological niches including habitats that are considered
harsh with respect to temperature, salt concentration,
pH pressure or nutrient availability. The particular stres-
ses imposed by such environments have been strong se-
lective forces in evolution. The ability of microbes to
adapt regardless of environmental conditions has yield-
ed enormous genetic diversity, which vastly surpasses that
of their eukaryotic counterparts.
Until recently investigation of prokaryotic diversity
had been inaccessible. To be studied, microbes had to be
obtained in pure culture, limiting prokaryote recovery to
less than one percent of cells present in a given popula-
tion (1). In the past decade, the development of high
throughput sequencing technology had permitted the
generation of large datasets of environmental DNA se-
quences without the need for prior cultivation. A new
field, metagenomics, has emerged unveiling the extent
of microbial genetic potential and diversity in the envi-
ronment.
Here we highlight two examples of prokaryotic ge-
nomic diversity: on an intraspecies level, exemplified by
the highly versatile Escherichia coli, and the diversity in
the hypersaline environment. Health issues, particularly
related to the food chain, and biotechnological potential
are discussed.
Intraspecies Diversity among Escherichia coli
Escherichia coli is a Gram-negative rod-shaped ente-
robacteria found in the intestine of humans and many
animals. E. coli is the prototypic commensal species of
the facultative anaerobic microbiota in the lower intes-
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tine of healthy warm-blooded organisms. It is also the
most abundant facultative anaerobe of the human gut
microbiota. Commensal E. coli inhabits the mucous layer
of the colon and colonizes the gastrointestinal tract of in-
fants within a few hours after birth (2). Nevertheless, E.
coli is a highly versatile species, hence, strains are also
isolated from the environment, namely plants, soil, wa-
ter and food.
In healthy humans, different E. coli clones often co-
exist, with some being more abundant or predominant
than others (3). A complete turnover in the E. coli gut
population is established within a period of two weeks
to a month (4). In 2013, Smati et al. (5) identified a small
reservoir of E. coli clones that are present in the human
gut, the so-called minor clones. Their presence could ex-
plain fluctuations in the composition of the E. coli micro-
biota observed within individuals. It is also well estab-
lished that the composition of the gut microbiota, including
E. coli strains, is affected by host species, diet and physi-
ology (6).
E. coli strains can be assigned to one of four main
phylogenetic groups: A, B1, B2 and D, on the basis of
allelic variation at enzyme-encoding genes detected by
multilocus enzyme electrophoresis (7,8). The individual
phylogenetic groups are associated with particular ecolo-
gical niches, thus strains belonging to B2 and D groups
are generally considered as extraintestinal and virulence
associated in humans, while A and B1 groups are gener-
ally commensal. Clermont et al. (9) established a rapid and
simple method to determine E. coli phylogenetic groups
employing a triplex PCR based on the amplification of
three fragments (a fragment of the chuA gene, a frag-
ment of the yjaA gene, and a fragment of the TSPE4.C2
noncoding sequence). The presence or absence of combi-
nations of these three amplicons is used to assign E. coli
to one of the four phylogenetic groups. In order to in-
crease the discriminative power of phylogenetic group
analysis, Escobar-Páramo et al. (10) proposed to further
define the combinations of the three amplicons using
phylogenetic subgroups (A0, A1, B22, B23, D1 and D2). In
addition, most enterohaemorrhagic E. coli (EHEC), in-
cluding O157:H7, are assigned to the minor phylogen-
etic group E (11). Several roles have been assigned to
commensal E. coli: (i) protection of the host against colo-
nization by pathogenic bacteria, (ii) breakdown of nutri-
ents/waste products, and (iii) synthesis of vitamin K.
Pathogenic E. coli
Normally commensal E. coli and its human host can
coexist with mutual benefit for decades. Nevertheless,
certain E. coli strains can cause an extensive variety of
intestinal and extraintestinal infections, and several patho-
vars have been defined (2). Enteropathogenic E. coli
(EPEC) are characterized by attaching and effacing le-
sions in the ileum; EHEC provoke haemorrhagic colitis
(HC) with attaching and effacing (A/E) lesions similar
to those of EPEC, and due to the production of Shiga
toxin (also designated verotoxin) may cause haemolytic-
-uraemic syndrome (HUS) with severe renal damage.
Enterotoxigenic E. coli (ETEC) produce heat-stable (ST)
and heat-labile (LT) enterotoxins to provoke infantile di-
arrhoea and traveller’s diarrhoea. Two additional intesti-
nal pathogenic pathovars are the enteroaggregative and
enteroinvasive E. coli (EAEC and EIEC, respectively). Ex-
traintestinal pathogenic E. coli (ExPEC) strains have the
ability to cause disease at multiple anatomical sites, e.g.
urinary tract infections (UTI), neonatal meningitis (NMEC),
pneumonia, skin and soft tissue infections, and sepsis
(12). A number of virulence factor genes of the E. coli
pathovars are located on pathogenicity islands, which
are characterized by a G+C content different from that
of the rest of the chromosome and are generally acquired
via horizontal gene transfer.
Pathogenic E. coli strains that provoke infections en-
code characteristic virulence factor genes (2). Any com-
ponent of a microbe that is required for, or potentiates
its ability to cause disease is designated as a virulence
factor. Characteristic groups of virulence factors are: ad-
hesins, toxins, iron uptake systems and host immunity-
-evading systems. Virulence factors facilitate colonization
and invasion of the host, avoidance or disruption of host
defence mechanisms, injury to host tissue, and/or stimu-
lation of excessive fluid and electrolyte secretion or stimu-
lation of noxious host inflammatory response (13). Ad-
hesins are among the first virulence factors that come
into play during establishment of an infection. Besides
their primary role as adhesin molecules, they can also
function as invasins, promoters of biofilm formation and
transmitors of signals to epithelial cells resulting in in-
flammation. Various adhesins have been identified and
studied (14). The most common, encoded in many path-
ogenic and commensal E. coli, are type-1 fimbriae, which
are generally not regarded as virulence factors (15). Tox-
ins are important virulence factors in a variety of E. coli-
-mediated intestinal and extraintestinal diseases that affect
an astonishing variety of fundamental eukaryotic pro-
cesses and thereby harm the host; they can also act as
invasins (2). Bacteria have developed specialized uptake
systems to capture iron, an essential cofactor for many
basic bacterial metabolic pathways. The most prominent
iron uptake systems are the siderophores, iron-binding
molecules that are taken up by special siderophore re-
ceptors and ATP-consuming porin-like transporters in the
bacterial outer membrane (16). In addition to siderophore
synthesis, strains can use siderophores produced and re-
leased into the extracellular medium by other bacteria
and even fungi (17). Apart from the siderophores and
their receptors, autotransporters, virulence-associated pro-
teins in Gram-negative bacteria, can also play a role in
obtaining iron, for example the haemoglobin protease Hbp
(18). A wide array of host immunity-evading systems,
ranging from polysaccharide capsules to serum-resistant
proteins, are known in pathogenic E. coli (2). Capsules
are discrete structural layers of extracellular polysaccha-
rides that protect pathogens from assaults such as opso-
nophagocytosis and complement-mediated killing (19);
and in the case of acidic polysaccharide capsules (K an-
tigens), they can act as 'sponges' to sequester and neu-
tralize antimicrobial peptides (20). Another virulence fac-
tor that E. coli uses to avoid host defence is TcpC, a Toll/
interleukin-1 receptor (TIR) domain-containing protein
that inhibits Toll-like receptor (TLR) and MyD88-specific
signalling, thus impairing the innate immune response
(21). Notably, E. coli strains causing intestinal and extra-
intestinal infections have different arrays of specific vir-
ulence factors. Assignment of pathogenic E. coli strains
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into pathovars is based on the carriage of a common set
of virulence factor genes (2) (Table 1).
The gut microbiota represents a reservoir of virulence
determinants for intestinal and extraintestinal pathogen-
ic E. coli strains and thus, the genetic armory of the fae-
cal E. coli population is important in the pathogenetic
potential of its flora (3). This has been indicated by stud-
ies directed to commensal E. coli strains that possess viru-
lence factors typical for extraintestinal pathogenic E. coli
(Table 2; 22–27).
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Table 1. Escherichia coli pathotypes and characteristic virulence factors
Pathotype Adhesin Toxin
Intestinal pathogenic E. coli
enterotoxigenic E. coli (ETEC) fimbriae CF, fimbriae K88,




enteropathogenic E. coli (EPEC) fimbriae Bfp, intimin
enteroinvasive E. coli (EIEC) similar to Shigella spp. similar to Shigella spp.
enterohaemorrhagic E. coli (EHEC) intimin Shiga-like toxin (Stx), enterohaemolysin (E-Hly)
enteroaggregative E. coli (EAEC) fimbriae GVVPQ enteroaggregative heat-stable (EAST), enterotoxin
necrotoxic E. coli (NTEC) fimbriae P cytotoxic necrotizing factor (CNF)
Extraintestinal pathogenic E. coli
uropathogenic E. coli (UPEC) fimbriae P
fimbriae S
Afa/Dr family of adhesins
haemolysin (Hly)
cytotoxic necrotizing factor (CNF)
uropathogenic specific protein (Usp)
sepsis/meningitis-associated E. coli (MNEC) fimbriae S, K1-capsule invasin (Ibe)
Table 2. Prevalence of ExPEC virulence factors among faecal or rectal Escherichia coli isolates in different studies
N(isolates)/%
A B C D E F
Virulence factor (VF)
Toxin
cnf1 5 (6) 6 (4) n.a. 6 (7) 9 (13) 3 (5)
hlyA/hlyD 7 (8) 7 (4) 15 (20) 10 (11) 10 (14) 6 (9)
usp 22 (24) n.a. n.a. n.a. n.a. n.a.
ibeA 12 (13) 3 (2) 7 (9) n. a. 11 (15) 4 (6)
Adhesin
fimH 79 (88) n.a. 70 (92) 87 (99) 65 (92) 64 (96)
papGII + GIII 10 (11) n.a. 3 (4) n.a. 19 (27) 7 (10)
sfa/foc 15 (17) 6 (4) 4 (5) 11 (13) 11 (15) 6 (9)
afa/draBC (drb) 4 (4) 2 (1) 4 (5) 2 (2) 4 (6) 0 (0)
Iron uptake system
aer (iucD/iutA) 35 (39) 27 (16) 20 (26) 35 (40) 14 (20) 20 (30)
fyuA 59 (66) n.a. 51 (67) n.a. 39 (55) 23 (34)
ireA 18 (20) n.a. n. a. n.a. 5 (7) n.a.
iha 35 (39) n.a. 13 (17) n.a. 10 (14) n.a.
hbp 14 (16) n.a. n.a. n.a. n.a. n.a.
Host immunity evading systems
kpsMTII 52 (58) n.a. 53 (70) 62 (70) 34 (48) 16 (24)
tcpC 7 (8) n.a n.a. n.a. n.a. n.a.
A=90 isolates from Slovenia (22); B=168 isolates, including 56 isolates from Paris, France, 57 isolates from Olib and Silba, Croatia,
and 55 isolates from Mali (23); C=76 isolates from Minneapolis, USA (24); D=88 isolates from Michigan, USA (25); E=71 isolates from
Minneapolis, USA (26); F=67 isolates from Barcelona, Spain (27). n.a.=not applicable
Foodborne E. coli
Foodborne infections are of great health and econom-
ic significance. Therefore, analyzing foods using standard
phenotypical methods for the presence of foodborne path-
ogenic bacteria is a routine procedure in Slovenian food
producing and processing plants. Some E. coli strains are
significant foodborne patogens causing diverse diarrho-
eal diseases. The most important and the only recognized
zoonotic E. coli strains in Slovenia so far have been clas-
sified as enterohaemorrhagic Escherichia coli (EHEC). The
hallmark of these strains is the production of Shiga-like
toxins/verotoxins; therefore, they are often denoted as
Shiga toxin-producing E. coli (STEC)/verotoxin-produc-
ing E. coli (VTEC). STEC cause a spectrum of human
diseases, including bloody diarrhoea, haemorrahagic co-
litis (HC) and haemolytic-uraemic syndrome (HUS) usu-
ally following consumption of contaminated food (2,28,
29). A large variety of VTEC serotypes have been associat-
ed with disease, the most prevalent being O157:H7. How-
ever, enterohaemorrhagic E. coli O26:H11 has recently
emerged as the most important non-O157:H7 pathogen
(30,31). In accordance, data for Slovenian VTEC isolates
indicate that the number of O26:H11 belonging to phylo-
genetic group B1 is steadily increasing (Trkov, unpub-
lished results). Recently, a study performed at the De-
partment of Biology, Biotechnical Faculty, University of
Ljubljana, and the Institute of Public Health of the Re-
public of Slovenia, assessed food supply as a possible
source of antimicrobial-resistant and VTEC strains. Sixty
E. coli isolates from different food items (vegetables, raw
meat products, sausages, etc.) were screened with PCR
for the presence of enterovirulence genes vtx1, vtx2, eae,
ehxA, ipaH, eltA, and estA and assigned to a phylogenetic
group according to Clermont et al. (9). While one isolate
belonged to either the extraintestinal virulence-associat-
ed phylogenetic group B2 or D, forty-three isolates were
assigned to the low-virulence, predominantly commen-
sal phylogenetic group A and sixteen isolates to group
B1. Although strains of phylogenetic group B1 are re-
ported to be predominantly commensal, five out of 16
B1 isolates carried at least one of the virulence genes as-
sociated with VTEC strains. Thus, genes for intimin (eae)
and EHEC-associated enterohaemolysin (ehxA) were found
in one isolate from minced meat with spices and differ-
ent vtx alleles alone or in combination with ehxA in other
five isolates from raw beef and tartar beefsteak (32). In a
second study, sixty-six E. coli isolates from patients’ stool
samples from the Ljubljana region, with diarrhoea of un-
known origin were analysed. Twelve isolates were deter-
mined as E. coli O26 and all belonged to phylogenetic
group B1. They carried an eae gene, nine were ehxA posi-
tive and two carried an additional vtx1 or vtx2 gene.
Further, six isolates were determined as O157. All car-
ried the eae gene and additionally either the ehxA and/
or vtx2 gene (32). The treatment of EHEC infections with
bactericidal antibiotics, particularly with b-lactams, is gen-
erally not recommended due to possible induction of
Shiga toxin production (33).
Other non-EHEC enteropathogenic strains of E. coli
cause generally less severe infections with few complica-
tions in developed countries. These infections are rarely
treated with antimicrobial agents. It is likely, therefore,
that less attention has been dedicated to less pathogenic
and nonpathogenic E. coli strains originating from food,
animals used for food, animal food production systems
and other environments, although they are often a per-
manent or transient part of the microbial community of
the human gastrointestinal tract. As certain E. coli strains
have been studied solely in terms of human and avian
pathogens, horizontal gene transfer of virulence and re-
sistance genes between strains of different origin, aided
by the abundant use of antibiotics in human/veterinary
medicine and food production systems, has been com-
pletely overlooked. Consequently, new pathogenic and/
or antimicrobial-resistant strains emerge 'unexpectedly',
as for example the EHEC O104:H4 outbreak in Germany
in 2011 (34,35).
Foodborne E. coli as a source of antibiotic resistance
genes
The emergence of antibiotic-resistant bacteria has be-
come one of the major challenges of global health care
systems, both from the point of view of economic and
human costs (36). Hospitals were traditionally consid-
ered to be the major selective environment of antibiotic-
-resistant bacteria and genes. However, the increasing
frequency of some, previously almost exclusively hospi-
tal-associated infections, e.g. infections caused by extend-
ed-spectrum b-lactamase (ESBL)-producing E. coli, among
community-dwelling patients has prompted researchers
to consider other reservoirs of resistant strains and/or
genes. Recently, it has been proposed that the dissemina-
tion of resistances to b-lactams and other antimicrobials
in the community could also occur through the food chain
from animal production environments, where antimicro-
bials have been administered for therapeutic and pro-
phylactic use, as well as growth promoters since the mid
1940s (37). The major mechanism of resistance to b-lactam
antibiotics in E. coli and other Gram-negative species is
the production of b-lactamases. In the last two decades
numerous ESBL enzymes that hydrolyse extended-spec-
trum cephalosporins evolved due to mutations in TEM-1,
TEM-2, SHV-1 and CTX-M genes. The genes are located
on chromosomes and plasmids. The latter are success-
fully disseminated through horizontal gene transfer
among the Enterobacteriaceae and even broader. The pres-
ence of ESBL-producing E. coli in the intestinal tract of
food-producing animals has recently been described by
several authors (reviewed in 38–40). Of particular con-
cern is the steady increase in the prevalence of E. coli
and other bacterial species producing ESBL and/or AmpC
enzymes in food-producing animals such as poultry, cat-
tle, swine, horses and rabbits, and food products in dif-
ferent European countries. Indeed, several authors have
suggested a possible transmission of ESBL-producing E.
coli from poultry to humans, most likely through the
food chain. Leverstein-van Hall et al. (41) compared E.
coli isolates from retail chicken meat, food-producing an-
imals and humans and found that 19 % of the human
isolates carried ESBL genes on plasmids that were genet-
ically indistinguishable from those obtained in poultry
isolates, and that 94 % of the retail chicken meat was
contaminated with ESBL-producing E. coli, of which 39 %
had the same genotypes as the ones found in human iso-
lates. On the other hand, a comparative analysis showed
a high diversity in virulence and antimicrobial gene con-
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tents among ESBL-positive E. coli isolates from animals
and humans from the UK, the Netherlands and Ger-
many. The genotypes of the majority of the isolates from
humans were different from those isolated from animals,
while many human isolates from the compared coun-
tries were similar. However, the results should be inter-
preted in light of the fact that nearly half of the human
isolates belonged to or were highly similar to the pan-
demic clonal group ST131 (42). Different prevalence of
ESBL/AmpC-producing isolates in different countries
could partly be the result of various amounts of anti-
microbials used in food-producing animals. Dierikx et al.
(43) detected ESBL/AmpC-producing isolates in cloacal
swabs from broilers at all 26 tested broiler farms in the
Netherlands, which, compared with other European coun-
tries, use more antimicrobials for the treatment of food-
-producing animals. However, they also found a high pre-
valence of ESBL/AmpC-positive birds at one farm that
did not use any antimicrobials during the whole produc-
tion period. In Slovenia, the prevalence of ESBL/AmpC-
-producing E. coli in food animals and slaughterhouses
has been studied since 2009. One of the studies included
72 strains isolated from samples of slaughtered poultry
in the period between October 2011 and May 2012. Fifty-
-five (76.3 %), one (1.3 %) and sixteen (22.2 %) isolates
carried group CTX-M-1, CTX-M-2 and SHV genes, re-
spectively. Twenty-one (29 %) belonged to phylogenetic
group A0, 23 (31 %) to group B1, and 29 (40 %) to group
D (39,44). Virulence genes iha, kpsMTII, fluA and usp,
which are associated with human pathogenic E. Coli,
were also detected (unpublished results). These data are
worrisome since foodborne bacteria that enter the hu-
man gastrointestinal tract may become a constant part of
the human endogenous microbiota (45). Recently, some
authors have suggested that food is a possible source of
ExPEC strains associated with different (e.g. urinary tract)
infections (46,47). This possibility should not be under-
estimated. It is also of concern that metallo-b-lactamase-
-producing E. coli was recently isolated from mastitic milk
samples (48). New Delhi metallo-b-lactamases, NDM1, in-
activate carbapenems, powerful b-lactam antibiotics with
broad spectrum antibacterial activity, employed as anti-
biotics of last resort for multiresistant Klebsiella pneumo-
niae and E. coli strains. It would therefore be an extreme-
ly alarming scenario if carbapenemase-resistant strains
and/or resistance genes could easily, via food, enter our
gastrointestinal tract – particularly if we consider that
enterobacteria carrying e.g. an blaNDM gene are resistant
to almost all antimicrobials except colistin and tigecy-
cline (49).
Mechanisms shaping E. coli genomic diversity
The primary mechanisms shaping E. coli genomic di-
versity are mutations, horizontal gene transfer, and bac-
teriocin production. E. coli naturally transfers DNA by
two mechanisms of horizontal gene transfer, conjugation
and transduction. Conjugation proceeds between two bac-
terial cells and is driven by conjugative plasmids, while
transduction is mediated by bacteriophage. Both conju-
gation and tranduction are known to promote the dis-
semination of virulence and antibiotic resistance genes.
Mutations can be either spontaneous or induced. In ad-
dition, DNA damage in E. coli activates the SOS response,
a coordinated DNA damage response, which induces er-
ror-prone DNA polymerases to promote an elevated mu-
tation rate and horizontal gene transfer. The SOS response
thus generates genetic diversity, adaptation, but also evo-
lution of antibiotic resistance, control of virulence factor
synthesis and dissemination of antibiotic resistance as well
as virulence factors.
Two proteins control the SOS response, a repressor
LexA and an activator RecA. In the absence of DNA dam-
age, a LexA dimer represses transcription of more than
50 genes including lexA and recA by binding to SOS box-
es (a 20-base-pair consensus palindromic DNA sequence).
Upon DNA damage, RecA is activated (RecA*) after bind-
ing to a single-stranded DNA (ssDNA), forming a nucleo-
protein filament. RecA* stimulates self-cleavage of LexA
leading to derepression of SOS genes (50).
While food is a source of infection, it is also a source
of mutagens, introduced either as preservatives, flavour
enhancers or produced during food processing (51). Mu-
tagenic substances damage DNA, but they are not neces-
sarily carcinogenic to human cells, since they may be al-
tered (e.g. detoxified in the liver) or do not have the
abiliy to enter a human cell. Direct correlation between
mutagenicity and carcinogenicity is thus broken, the risk
of non-carcinogenic mutagens is downgraded.
Nevertheless, some food additives (e.g. sodium ni-
trate, effective via nitrous acid transformation), although
regarded 'safe' for human consumption, provoke DNA
damage in intestinal bacteria and trigger the SOS re-
sponse. In an attempt to repair DNA damage, this stress
response leads to increased rearrangements within the
genome and opens a Pandora’s box of genetic elements
that are mobilized, including latent bacteriophages, trans-
posons and plasmids, able to spread among related bac-
teria (52). In addition, an increase in mutation rate paves
the path for pathogens to acquire a new or increase the
existing antibiotic resistances, and to accumulate and
spread pathogenicity factors.
Further potential factors that affect the bacterial SOS
response are antibiotics, used for human therapy as well
as in veterinary medicine either for disease treatment
and prevention or as growth promoters in food animals.
Although the risk to human health seems negligible (53),
presumably innocuous concentrations of some antibiot-
ics, particularly fluoroquinolones, increase the expres-
sion of SOS-controlled genes (54). Alarmingly, even fresh
vegetables could accumulate the extensively used fluo-
roquinolone ciprofloxacin, when sewage sludge contain-
ing drug residues is used as a fertiliser (55).
As the development of new antibiotics, particularly
for new bacterial targets, is at a standstill, different ap-
proaches should be explored. The life-span of the exist-
ing antibiotics could be prolonged by blocking bacterial
adaptation, controlled at least in part by the SOS system.
In recent years, a three-dimensional model of the com-
plex between LexA and RecA proteins has emerged (56,
57), revealing some potential sites for the design of se-
lective inhibitors.
Bacteriocins
In addition to the diversity of virulence factor pro-
duction and antibiotic susceptibility, E. coli strains also
exhibit a high level of diversity of bacteriocin produc-
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tion. Bacteriocins are produced by all major lineages of
bacteria as well as some archea presumably for defense
or invasion of ecological niches. Bacteriocin activity was
initially described in Escherichia coli in 1925 by Gratia
(58). The most extensively studied are bacteriocins of the
Enterobacteriacae, particularly those of E. coli designated
colicins (59). Approximately 40 % of E. coli strains pro-
duce colicins.
E. coli strains produce two types of bacteriocins, co-
licins and microcins. Colicins are plasmid-encoded, high
molecular mass bacteriocins (>20 kDa). More than 20
colicin types have been described. Evolutionary investi-
gations of colicin diversity have revealed two modes of
evolution: recombination characteristic of pore formers
and point mutations among nuclease colicins (60). Gen-
erally, colicin production and release are encoded by a
cluster of three genes: (i) the activity gene for colicin
synthesis, (ii) immunity gene for protection of the pro-
ducing cell, and (iii) a lysis gene for semispecific colicin
release by cell lysis (59,61).
Killing of a sensitive cell proceeds by colicin bind-
ing to a specific receptor in the outer membrane, fol-
lowed by translocation through the outer membrane via
the Tol or TonB translocation system to the target. Coli-
cins exhibit a three-domain structure: the N-terminal do-
main for translocation of the colicin into the target cell,
the central domain for binding of the colicin to a specific
cell surface receptor, and the C-terminal catalytic domain
with a short region for binding of the immunity protein.
Colicins destroy sensitive cells by one of three mech-
anisms: (i) pore formation, (ii) nuclease activity, DNA or
RNA degradation, or (iii) inhibition of peptidoglycan and
lipopolysaccharide O-antigen synthesis.
Colicins have been shown to mediate population
and community level interactions (62–64) promoting mi-
crobial diversity within E. coli populations in the mam-
malian colon (65). In addition, investigation of the trans-
criptional response of E. coli to the nuclease colicins, E3
and E9 revealed that the former upregulated genes of
mobile genetic elements (phage recombinases, insertion
sequence origin) while the latter upregulated the dam-
age-inducible SOS response including the error-prone
DNA polymerase V, suggesting that colicins may also
promote genetic diversity in E. coli populations (66). Co-
licin synthesis is controlled primarily by the DNA-dam-
age-inducible SOS system, as the synthesis is repressed
by its key regulator, the LexA protein (59). The large ma-
jority of colicin operons harbour two overlapping LexA
boxes located downstream of the Pribnow box (67) to
which two LexA dimers bind. The two LexA boxes effec-
tively repress expression, protecting the producer from
overt lysis (68). Upon DNA damage, most SOS genes are
induced almost immediately while colicin-encoding ope-
rons are expressed following a pronounced lag (69). The
lag in expression is presumed to assist surviving cells by
killing competitors (70). Regulation by the transcription-
al regulator CRP (cAMP receptor protein)-cAMP complex
as well as the IscR (iron-sulphur cluster) transcriptional
regulator have been shown to provoke a lag in expres-
sion of some colicins. Thus, in the absence of DNA dam-
age in metabolically active cells, the pore-forming colicin
K synthesis is repressed by the LexA and IscR repres-
sors. Only after a prolonged SOS response and as me-
tabolism slows down due to nutrient exhaustion, is coli-
cin synthesis induced presumably to eliminate defective
cells as well as to provide nutrients to related neigh-
bours (69). A post-transcriptional regulatory mechanism
involving the stringent response has been shown to reg-
ulate colicin K synthesis (71). Furthermore, a recent study
has shown that some colicin-producing strains induce ex-
pression of other colicins (70).
Compared to colicins, microcins are smaller molecu-
lar mass bacteriocins (<10 kDa). They are generally hy-
drophobic, heat and pH stable and resistant to protease
degradation. Gene clusters for microcin synthesis har-
bour genes for the microcin precursor, immunity, secre-
tion proteins and modification enzymes. Microcins ex-
hibit a narrow antimicrobial spectrum of activity against
phylogenetically related species and are therefore pre-
sumed to be engaged in competition within the intesti-
nal tract. Stress such as nutrient depletion has been
shown to induce microcin synthesis (72).
To obtain insight into the roles that bacteriocins play
among E. coli populations, various collections of strains
have been examined for the presence of colicins and
microcins. Thus, among a collection of strains from pa-
tients with bacteraemia of urinary tract origin, 66 % of
the strains encoded at least one bacteriocin, with 43 %
encoding one or more colicins and 54 % one or more
microcins. Among the bacteriocin-encoding strains, 43 %
encoded one type of bacteriocin, 45 % two, 8 % three
and 4 % encoded four different bacteriocins (73). Fur-
thermore, the analysis revealed that among strains of the
B2 phylogenetic group, most strains encoded more than
one bacteriocin, while bacteriocins were least frequent
among strains of the B1 group. On the other hand, the
majority of microcin-encoding strains belonged to the B2
phylogenetic group. Microcins were found to co-occur
with toxins, siderophores, adhesins and the Toll/inter-
leukin-1 receptor domain-containing protein TcpC. The
results indicated that microcins contribute to virulence
of E. coli, provoking bacteraemia of urinary tract origin.
Application of bacteriocins
The discovery of penicillin and subsequently other
antibiotic classes represented milestones in the battle
against infectious diseases. However, the misuse and
overuse of antibiotics has prompted the emergence and
spread of antibiotic resistances. Bacteriocins represent a
much needed alternative approach to control infections.
Of the bacteriocins produced by Gram-negative bacteria,
a number of studies have demonstrated that colicins are
effective against E. coli strains associated with diarrhoea
including serotype O157:H7 (74–80). In addition, colicins
have been shown to be effective against uropathogenic
strains (81) and to prevent colonization of urinary cathe-
ters (82). Colicin E1 also exhibited inhibitory activity
against L. monocytogenes in broth culture and in ready-
-to-eat (RTE) products (83), while colicins H and G ex-
hibited inhibitory activity against Salmonella strains iso-
lated from clinical cases (84).
Microbial Diversity in Hypersaline Enviroments
Dominance of a single genus or a species in a given
niche is highly unusual in prokaryotic communities. In-
stead, prokaryotes most often live in highly complex
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multispecies assemblages in which they interact with
one another (85). This complexity impedes our attempts
to understand some basic concepts in the evolution of
prokaryotic species: the mechanisms that generate and
maintain diversity and the mechanisms of interaction
with other biotic compounds. In these terms, extreme
environments can be considered as ideal model systems,
since they often support microbial communities that are
simple in structure: dominated by a single or a very
small number of prokaryotic species, with a vast diver-
sity of low-abundance species. Here we aim to summa-
rize findings on the diversity of prokaryotes in the hy-
persaline environment as well as some implications of
these findings in the evolution of prokaryotic species.
Metagenomics of solar saltern crystallizer
Early metagenomic studies on crystallizer brine re-
ported that its microbial community is composed mostly
of euryarchaeal Halobacteriaceae and halophilic members
of Bacteroidetes (86). In different salterns, prokaryotic
communities were fairly similar in terms of taxonomic
census but differed in the relative proportions of the
present taxa. These differences were attributed to local
differences in salt production technologies imposed by
prevailing weather conditions and geology (87,88). For
example, in the Slovenian Se~ovlje saltern, where salt pro-
duction is limited to the arid part of the year, the crys-
tallizer ponds are shallow and measure only a few centi-
metres in depth. As a consequence, the water retention
time is reduced to less than 24 h. It does not allow large
microbial blooms and supports up to 104 cells per mL
(88). Not surprisingly, the prokaryotic community is do-
minated by fast-growing members of the archaeal genus
Halorubrum (66 % of sequences retrieved) (88,89). Another
such example are the salterns of the Tamil Nadu region
in India, which are fed with hypersaline spring water
mixed with seawater and led to the ponds from bore-
wells. Although the salt production technology is very
similar to that in Slovenia, the differences in water com-
position result in the dominance of members of the arch-
aeal genus Natrinema (3 % of sequences) (90).
In contrast to the above salterns, salterns in arid ar-
eas allow for brine to be replenished on a yearly basis.
An example is the crystallizer of the Bras del Port sal-
tern, Spain, which is characterized by large numbers of
prokaryotic cells and virus-like particles, up to 109 per
mL (91). As shown recently in a large-scale metageno-
mic study, this brine is remarkably complex in terms of
taxonomy (92). However, in terms of community struc-
ture, the brine community is fairly simple. As indicated
in early studies (e.g. 86), a vast majority (up to 79.0 %) of
environmental 16S rRNA sequences can be affiliated
with a single species, Haloquadratum walsbyi. This species
is followed in abundance by the hyperhalophilic bacte-
rium Salinibacter ruber (9.0 %), while the remaining taxa
represent only a minor portion of the encountered diver-
sity (91).
Like many other prokaryotes that are either ecologi-
cally relevant or very abundant, Haloquadratum walsbyi is
difficult to cultivate. Today, only two isolates of this spe-
cies are available (93,94). The genomic sequence of the
H. walsbyi strain HBSQ001, originally isolated from the
Bras del Port saltern, Spain, was published in 2006 (95)
and the sequence of strain C23, originally isolated from
a saltern in Geelong (Australia) followed in 2011 (96).
Both genomes shed a number of signatures typical for
halophilic organisms: e.g. low GC content (in %) and the
presence of halophilic proteins. Likewise, two genomic
sequences of Salinibacter ruber are available, and corre-
spond to strains M31 and M8 isolated from the Salinas
de Levante in Majorca, Spain (97,98).
Another important aspect of a prokaryotic commu-
nity is its temporal dynamics. The stability of the crys-
tallizer communities at different time points was ad-
dressed in the Chula Vista saltern, California, USA (99).
This metagenomic study followed the composition and
metabolic potential of microbial and viral communities
at various time points ranging from 24 h to more than
one year. At the level of microbial species, both commu-
nity composition and metabolic potential remained sta-
ble with time. However, at the level of microbial strain
and viral genotype, the community experienced drama-
tic temporal changes. The study suggested that the ob-
served cycling of the taxa likely reflects the interplay at
the level of viral genotypes and virus-sensitive microbial
strains (99).
The above proposed concept was not entirely new.
Natural populations of bacterial species have long been
considered to be composed of distinct clonal lineages
(100). These are defined as asexual descendants of a
given genotype that differ from the originator only via
mutation and mitotic recombination. Judging by the pre-
dictions of competition of mutants in laboratory popula-
tions of Escherichia coli, the ecologically superior lineage
would eventually overcome all the others. This, in turn,
reduces genomic diversity (100). If such a population en-
counters an increase in predating virus population, then
a massive lysis event is expected to collapse the popula-
tion. Actually, these events are occasionally observed, par-
ticularly in man-made systems, for example in the lactic
industry (101).
Diversity among halophiles
Viral pressure is the main factor that controls the
relative abundance of crystallizer taxa (91). However, it
causes less than 5 % of prokaryotic losses and no mas-
sive lysis events (91). This indicates that the clonal lin-
eages of dominant species (i.e. Haloquadratum walsbyi and
Salinibacter ruber) might differ in phage susceptibility.
This intraspecies variability is reflected in genomic se-
quences either as the presence of variable genomic re-
gions that are absent from one or more lineages, or are
unique to certain lineages (102). One way to distinguish
the variable genomic regions from the core genome is to
tile metagenomic reads of the environment from which
the organism was isolated to its reference genome, a
method known as genomic recruitment. The regions that
are common to all lineages will be well represented in
the environment and will recruit a large number of high-
ly similar fragments of metagenomic DNA. In contrast,
highly variable regions will be underrepresented in the
plot and will form 'metagenomic islands'.
A genomic recruitment experiment performed using
genomic sequence of Salinibacter ruber M31T and the me-
tagenome of the Chula Vista saltern identified three meta-
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genomic islands (103). These presented a number of fea-
tures typical of highly unstable genomic regions. They
had atypically low GC content (56 vs. 66 %) and con-
tained three out of four phage integrases found in the S.
ruber genome. The average coding region densities of the
three metagenomic islands were 54.0, 64.7 and 45.4 %,
respectively, compared to 84.8 % for the whole S. ruber
genome. The regions further had high numbers of pseu-
dogenes and short hypothetical proteins. Compared to
the entire genome, the islands were enriched with genes
involved in carbohydrate transport and metabolism, cell
wall/membrane/envelope biogenesis, recombination, re-
plication and repair. Remarkably, while one island re-
sembled a lysogenic phage, two S. ruber islands con-
tained genes that code for cell-surface polysaccharides
and are involved in biosynthesis of polysaccharide com-
ponents of cell wall. This variability at the level of cellu-
lar envelope was suggested to play a role in defence
against phage predation. In fact, phages have been shown
to target lipopolysaccharides through their host recogni-
tion machineries (104) or strain-specific polysaccharases
(105).
The observed variability of gene clusters coding for
the polysaccharide component of the cell wall seems to
be a general phenomenon in prokaryotes. A similar pat-
tern of intraspecies genomic variability was observed in
the genomes of Haloquadratum walsbyi HBSQ001 and C23
(96,106), but also in available genomes of abundant ma-
rine microbes Candidatus Pelagibacter ubique, Prochlorococ-
cus marinus, Burkholderia sp. 383, Shewanella sp. MR-4,
Aeromonas hydrophyla ATCC 7966 and Synechococcus sp.
WH812 when compared to marine metagenome (107).
All species had metagenomic islands which contained
genes that encode extracellularly exposed products and
that could act as potential phage recognition sites.
Based on these observations, Rodriguez-Valera et al.
(107) proposed the constant diversity dynamics model
which assumes that the appearance of a mutant or re-
combinant that is ecologically superior to its peers leads
to only transient domination over ecologically less suc-
cessful lineages. Under this model, the expansion of in-
vasive lineage is met by an increase in numbers of vi-
ruses that target the lineage-specific cell-surface receptor.
This way, the invasive lineage is selected against and re-
placed by original normal fitness lineages avoiding mas-
sive losses. Therefore, under this model of population
dynamics, the high level of clonal lineage diversity is
steadily guarded by predating phage. It results in a large
pan-genome within the bacterial population as indicated
by metagenomic data and mathematical modelling (107).
Biotechnological aspects of adaptations to hypersaline
conditions
The solar saltern crystallizer brine is one of the
harshest environments with respect to total salt concen-
tration. It supports highly specialized halophilic archaea,
bacteria, fungi and viruses (e.g. 88,89,99,108). To com-
pensate for high extracellular sodium chloride concen-
tration, these organisms use two strategies. The so-called
'salt-in' halophiles (most of archaea) accumulate molar
concentrations of potassium and chloride, a strategy that
requires extensive metabolic adaptation. In contrast, the
'salt-out' halophiles (most of bacteria and fungi) accu-
mulate high intracellular concentrations of compatible
solutes.
The majority of enzymes originating from 'salt-in'
halophiles perform their functions in vitro and in vivo at
4.0–5.0 M NaCl (109). Halophilic enzymes offer the pos-
sibility to extend the repertoire of the already available
biocatalysts and aid in industrial processes where high
salt concentrations inhibit mesophilic enzymes. For in-
stance, highly salt-tolerant proteases of halophilic ar-
chaea are often also thermo- and alkalitolerant. For ex-
ample, a protease isolated from saltern dweller Haloferax
lucentensis VKMM 007 remained stable in the tempera-
ture range from 20 to 70 °C, at NaCl concentrations from
0.85 to 5.13 M and in pH range of 5.0–9.0. Furthermore,
it retained proteolytic activity in the presence of various
polar and non-polar solvents, surfactants and reducing
agents (110). Halophiles present other characteristics of
considerable biotechnological interest, such as bacterio-
rhodopsins, light-driven proton pumps used in photo-
electrochemical cells (111), carotenoid pigments and gas
vesicles – potential pathogen peptide delivery vehicles
(112–114). Halophiles have long been recognized in food
industry. Halophilic archaea are involved in the produc-
tion of various compounds that give the characteristic
taste, flavour and aroma to salt fish products such as
Thai fish sauce (nam pla) (115). In fact, the first halo-
philic microorganisms were discovered in spoiled foods
that were salted for preservation.
The high-salt tolerance of haloarchaea enables their
cultivation under non-sterile and cost-effective condi-
tions. However, such biotechnological advances are of-
ten hampered by long generation times of halophilic
archaea that range from 1.5 h for Haloterrigena turkmenica
(116) to up to 1–2 days reported for Haloquadratum wals-
byi (91). Recently, optimization of medium components
using response surface methodology resulted in signifi-
cant reduction of the time required for cell cultures of
halophilic archaea to reach the stationary phase while
providing a nearly 2.4-fold increase in biomass produc-
tion (117). This pioneering study proved that statistical
experimental design techniques are useful tools for screen-
ing for nutrients with significant impact on growth rate.
Conclusion
Prokaryotes display enormous intraspecies as well as
intra-habitat diversity. Mutations, horizontal gene trans-
fer, bacteriocin production and phage production are shap-
ing prokaryotic evolution and genomic diversity. While
E. coli isolates are part of the gut microbiota of man and
warm blooded animals, a number of pathovars with dis-
tinct combinations of virulence factors have evolved and
they provoke intestinal and extraintestinal infections. Of
great concern are those associated with the food chain
(e.g. EHEC and those carrying antibiotic resistance deter-
minants). In the hypersaline environment microbial com-
munities are dominated by a single or a very small
number of prokaryotic species and a vast diversity of
low-abundance species. Phage-host interactions have
been shown to control the relative abundance of taxa in
the crystallizer, while variable genomic regions indicate
intraspecies variability.
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